Physician profile
Luis E Bolano
NPI 1134186836
$3,524.06
in general payments reported to CMS, 2019-2025
16 companies · $82.10 in 2025
The $82.10 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $3,024 · 2021: $29.81 · 2022: $104 · 2023: $92.35 · 2024: $40.14 · 2025: $82.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,456.50 | 2020 | |
| Mid-Atlantic Surgical Systems, LLC | $533.97 | 2020 | |
| Skeletal Dynamics INC | $151.65 | 2019 | |
| Abbott Laboratories | $63.09 | 2022-2023 | Proclaim |
| Abbvie INC. | $56.71 | 2022-2025 | Teflaro |
| Smith+Nephew, INC. | $49.54 | 2022 | |
| Endo USA, INC. | $32.58 | 2025 | Xiaflex |
| Innovation Technologies INC | $28.73 | 2023 | Irrisept |
| Stryker Corporation | $25.26 | 2023 | T2 Alpha |
| Solventum Corporation | $24.31 | 2024 | V.A.C. Veraflo, Prevena |
| Globus Medical, INC. | $22.52 | 2025 | Senza |
| Paratek Pharmaceuticals, INC. | $18.28 | 2021 | |
| Convatec INC. | $16.81 | 2020 | |
| Endo Pharmaceuticals INC. | $16.75 | 2020 | |
| Ferring Pharmaceuticals INC. | $15.83 | 2024 | Euflexxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthogenrx INC. | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Bolano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.